Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model

Nutrition Journal

Volumn 9, Issue 1, 2010, Pages

  Bahar, Massih ^a   Khaghani, Shahnaz ^a   Pasalar, Parvin ^a   Paknejad, Maliheh ^a   Khorramizadeh, Mohammad Reza ^a   Mirmiranpour, Hossein ^a   Nejad, Siavash Gerayesh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; BUTHIONINE SULFOXIMINE; GELATIN; GELATINASE A; HYDROGEN PEROXIDE; MATRIX METALLOPROTEINASE INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE INHIBITOR; UBIDECARENONE; DRUG DERIVATIVE; ENZYME INHIBITOR; GLUTAMATE CYSTEINE LIGASE; MMP2 PROTEIN, HUMAN; SCAVENGER; UBIQUINONE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN FUNCTION; ZYMOGRAPHY; BREAST TUMOR; CARCINOMA; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; OSMOLARITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; TIME; TUMOR CELL LINE;

ACETYLCYSTEINE; BIOLOGICAL MARKERS; BREAST NEOPLASMS; BUTHIONINE SULFOXIMINE; CARCINOMA; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; FREE RADICAL SCAVENGERS; GLUTAMATE-CYSTEINE LIGASE; HUMANS; HYDROGEN PEROXIDE; MATRIX METALLOPROTEINASE 2; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; TIME FACTORS; UBIQUINONE;

EID: 78649485564     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-9-62     Document Type: Article

References (41)

1. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. R Roy J Yang MA Moses, J Clin Oncol 2009 27 5287 97 10.1200/JCO.2009.23.5556 19738110
2. The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Q Qian Q Wang P Zhan L Peng SZ Wei Y Shi, Cancer Invest 2010 28 661 9 10.3109/07357901003735634 20394501
3. Collagenases in cancer. R Ala-aho VM Kähäri, Biochimie 2005 87 273 86 10.1016/j.biochi.2004.12.009 15781314
4. Hypoxia and oxidative stress in breast cancer Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. NS Brown R Bicknell, Breast Cancer Res 2001 3 323 7 10.1186/bcr315 11597322
5. The signaling mechanism of ROS in tumor progression. WS Wu, Cancer Metastasis Rev 2006 25 695 705 10.1007/s10555-006-9037-8 17160708
6. Effect of the supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer. P Shekelle ML Hardy I Coulter J Udani M Spar K Oda, Evid Rep Technol Assess (Summ) 2003 75 1 3 15523748
7. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. S Yuvaraj VG Premkumar K Vijayasarathy SG Gangadaran P Sachdanandam, Clin Biochem 2007 40 623 8 10.1016/j.clinbiochem.2007.02.003 17425952
8. Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk. A Adhikary S Mohanty L Lahiry DM Hossain S Chakraborty T Das, FEBS Lett 2010 584 7 14 10.1016/j.febslet.2009.10.081 19883646
9. Andrographolide Exhibits Anti-Invasive Activity against Colon Cancer Cells via Inhibition of MMP2 Activity. HP Chao CD Kuo JH Chiu SL Fu, Planta Med 2010 20539971
10. The antioxidant role of coenzyme Q. M Bentinger K Brismar G Dallner, Mitochondrion 2007 Suppl 41 50 Epub 2007 Mar 16 10.1016/j.mito.2007.02.006 17482888
11. Clinical aspects of coenzyme Q10: an update. GP Littarru L Tiano, Nutrition 2010 26 250 4 10.1016/j.nut.2009.08.008 19932599
12. coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. O Portakal O Ozkaya M Erden Inal B Bozan M Kosan I Sayek, Clin Biochem 2000 33 279 284 10.1016/S0009-9120(00)00067-9 10936586
13. Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. N Hertz RE Lister, J Int Med Res 2010 38 293
14. Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy. P Sachdanandam, Biofactors 2008 32 151 9 10.1002/biof.5520320118 19096111
15. Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy. VG Premkumar S Yuvaraj K Vijayasarathy SG Gangadaran P Sachdanandam, Biol Pharm Bull 2007 30 367 70 10.1248/bpb.30.367 17268082
16. Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy. VG Premkumar S Yuvaraj S Sathish P Shanthi P Sachdanandam, Vascul Pharmacol 2008 48 191 201 10.1016/j.vph.2008. 02.003 18407793
17. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. L Rusciani I Proietti A Rusciani A Paradisi G Sbordoni C Alfano, J Am Acad Dermatol 2006 54 234 41 10.1016/j.jaad.2005.08.031 16443053
18. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. T Ito M Ito J Shiozawa S Naito T Kanematsu I Sekine, Mod Pathol 1999 12 669 74 10430270
19. SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. CJ Cheng YC Lin MT Tsai CS Chen MC Hsieh CL Chen, Cancer Res 2009 69 3634 41 10.1158/0008-5472.CAN-08-3615 19369267
20. Thiol supplementation inhibits metalloproteinase activity independent of glutathione status. P Bogani M Canavesi TM Hagen F Visioli S Bellosta, Biochem Biophys Res Commun 2007 363 651 5 10.1016/j.bbrc.2007.09.018 17900531
21. Biologic and pharmacologic regulation of mammalian glutathione synthesis. OW Griffith, Free Radic Biol Med 1999 27 922 35 10.1016/S0891-5849(99)00176-8 10569625
22. Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention. P Pei MP Horan R Hille CF Hemann SP Schwendeman SR Mallery, Free Radic Biol Med 2006 41 1315 24 10.1016/j. freeradbiomed.2006.07.014 17015178
23. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. S Das A Banerji E Frei A Chatterjee, Life Sci 2008 82 467 76 Epub 2007 Dec 27 10.1016/j.lfs.2007.12.013 18243246
24. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. AR Rosenkranz S Schmaldienst KM Stuhlmeier W Chen W Knapp GJ Zlabinger, J Immunol Methods 1992 156 39 45 10.1016/0022-1759(92)90008-H 1431161
25. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. VM Factor A Kiss JT Woitach PJ Wirth SS Thorgeirsson, J Biol Chem 1998 273 15846 53 10.1074/jbc.273.25.15846 9624185
26. Matrix metalloproteinase activity assays: Importance of zymography. K Kupai G Szucs I Hajdu C Csonka T Csont, J Pharmacol Toxicol Methods 2010 61 205 9 10.1016/j.vascn.2010.02.011 20176119
27. Determination of gelatinase A using a modified indirect hemagglutination assay in human prostate cancer screening and assessment of its correlation with prostate-specific antigen parameters. MR Khorramizadeh M Pezeshki A Ghahary H Zeraati A Berahmeh, Int J Urol 2005 12 637 43 10.1111/j.1442-2042.2005.01094.x 16045556
28. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. S Das A Banerji E Frei A Chatterjee, Life Sci 2008 82 467 76 10.1016/j.lfs.2007.12.013 18243246
29. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. A Ortega P Ferrer J Carretero E Obrador M Asensi JA Pellicer, J Biol Chem 2003 278 39591 9 10.1074/jbc.M303753200 12881529
30. Mitochondrial redox control of matrix metalloproteinases. KK Nelson JA Melendez, Free Radic Biol Med 2004 37 768 84 10.1016/j.freeradbiomed.2004.06.008 15304253
31. Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to triphala and its modification by antioxidants. T Sandhya KP Mishra, Cancer Lett 2006 238 304 13 10.1016/j.canlet.2005.07.013 16135398
32. Changes in matrix metalloproteinases activities in normal and transformed mouse fibroblasts under effect of antioxidants. IV Voronkina KM Kirpichnikova LV Smagina IA Gamali Tsitologiia 2008 50 877 81 19062520
33. Thiol supplementation inhibits metalloproteinase activity independent of glutathione status. P Bogani M Canavesi TM Hagen F Visioli S Bellosta, Biochem Biophys Res Commun 2007 363 651 5 10.1016/j.bbrc.2007.09.018 17900531
34. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. SC Tyagi S Kumar S Borders, J Cell Biochem 1996 61 139 51 10.1002/(SICI)1097-4644(19960401)61:1<139::AID-JCB15>3.0.CO;2-J 8726363
35. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. JS Lazo SM Kuo ES Woo BR Pitt, Chem Biol Interact 1998 111-112 255 262 10.1016/S0009-2797(97)00165-8 9679559
36. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. P Brenneisen K Briviba M Wlaschek J Wenk K Scharffetter-Kochanek, Free Radic Biol Med 1997 22 515 24 10.1016/S0891-5849(96)00404-2 8981044
37. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Wenk P Brenneisen M Wlaschek A Poswig K Briviba TD Oberley, J Biol Chem 1999 274 25869 76 10.1074/jbc.274.36.25869 10464329
38. Functions of coenzyme Q10 in inflammation and gene expression. C Schmelzer I Lindner G Rimbach P Niklowitz T Menke F Döring, Biofactors 2008 32 179 83 10.1002/biof.5520320121 19096114
39. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. VM Factor A Kiss JT Woitach PJ Wirth SS Thorgeirsson, J Biol Chem 1998 273 15846 53 10.1074/jbc.273.25.15846 9624185
40. Coenzyme Q10 - its role as a prooxidant in the formation of superoxide anion/hydrogen peroxide and the regulation of the metabolome. AW Linnane M Kios L Vitetta, Mitochondrion 2007 Suppl 51 61 Epub 2007 Mar 30 10.1016/j.mito.2007. 03.005 17482887
41. Comparison of Lipoamide dehydrogenase activity in HL-60 Leukemia cells and normal lymphocyte. N Abbasi S Khaghani A Sharif-Tabrizi B Farzami S Vardasbi M Bahar, et al. Acta Medica Iranica 2007 45 282 284